Lydie Boyvin, Zazou Ange Kevin Zokoré, Aya Jeanne Armande Aké, Yao Nestor N’Guessan, Kipré Laurent Séri, Adou Francis Yapo and Allico Joseph Djaman. Importance of Measuring Serum C-peptide in the Biological Care of Hyperglycemia Patients and Diabetics’ Patients on Insulin in Côte d’Ivoire.
. 2018; 6(1):16-20. doi: 10.12691/AJMBR-6-1-4
Côte d’Ivoire, C-peptide, Diabetes, Hyperglycemia, Insulin
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | WHO. Global report on diabetes. 2016. Geneve. WHO_NMH_NVI_16.3_ |
|
[2] | Hirst M. Atlas du diabète, 2013. USA. Sixième édition, ISBN. 160 p. |
|
[3] | WHO/IDF. International Diabetes Federation (IDF). Annual Report 2014. Resources/2015-atlas WHO/IDF (International Diabetes Federation). 2015. 144 p. |
|
[4] | Geoffroy L, Gonthier M. L’hyperglycémie et l’acidose diabétique. In Le diabète chez l’enfant et l’adolescent. Montréal, 2éd. Éditions du CHU Ste-Justine. 2012; 355-364. |
|
[5] | Grimaldi A, Bosquet F, Halbron M, Hartemann-Heurtier A, Jacqueminet S, Masseboeuf N, Sachon C. Guide pratique du diabète. 2005. Paris. ed Masson, Elsevier 271 p. |
|
[6] | Vasic, D. & Walcher, D. Proinflammatory Effects of C-Peptide in Different Tissues. International Journal of Inflammation, ID 932725: 1-7.2012. |
|
[7] | Vezzosi, D., Bennet, A., Fauvel, J., Caron, P. Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. European Journal of Endocrinology, 157(5):693. Nov 2007. |
|
[8] | Akuri, R.S., Suleman, D. Role of c-peptide and c-peptide glucose ratio in assessing decreased beta cell function in chronic pancreatic disorders. World Journal of Pharmacy and Pharmaceutical Sciences, 3(8): 2156-2163. 2014. |
|
[9] | Zhang, J. & Liu, F. Tissue-specific Insulin Signaling in the Regulation of Metabolism and Aging. International Union of Biochemistry and Molecular Biology Life, 66: 485-495. 2014. |
|
[10] | Deyhimi, F., Arabie, M., Parvin L. Optimization of the Emerson–Trinder enzymatic reaction by response surface methodology. Biocatalysis and Biotransformation, 24: 263-271. 2006. |
|
[11] | Gaillard, O. Le peptide C. Immuno-analyse & Biologie Spécialisée, 15: 94-95. 2000. |
|
[12] | Jones G A, Hattersley T A. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabetic Medicine, 30: 803-817. 2013. |
|
[13] | Martín-Timón, I., Sevillano-Collantes,C., Segura-Galindo, A., del Cañizo-Gómez, FJ. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World Journal of Diabetes, 5(4):444-470. 2014 |
|
[14] | Schnell, O., Cappuccio, F., Genovese, S., Standl, E., Valensi, P. et al. Type 1 diabetes and cardiovascular disease. Cardiovascular Diabetology, 12: 156. 2013. |
|
[15] | Boyda, H.N., Procyshyn, R.M., Tse, L., Hawkes, E., Jin, C.H., Pang, C.C., Honer, W.G., Barr, A.M. Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats. Journal of Psychiatry & Neuroscience, 37: 407- 415. 2012. |
|
[16] | Sayed M H, Hegazi M A, Abdulwahed K, Moussa K, El-Deek B S et al. Risk factors and predictors of uncontrolled hyperglycemia and diabetic ketoacidosis in type 1 diabetic children and adolescents, in Jeddah, Western Saudi Arabia. Journal of Diabetes, 2016. |
|
[17] | Umpierrez G E, Isaacs S D, Bazargan N, You X, Thaler L M, Kitabchi A E. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. Journal of clinical endocrinology and metabolism, 87: 978-982. 2002. |
|